Salarius Pharmaceuticals: Q1 Earnings Insights

Salarius Pharmaceuticals SLRX reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

Salarius Pharmaceuticals missed estimated earnings by 44.44%, reporting an EPS of $-0.13 versus an estimate of $-0.09.

Revenue was down $1.27 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 26.62% drop in the share price the next day.

Here's a look at Salarius Pharmaceuticals's past performance:

To track all earnings releases for Salarius Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.